Clinical features and prognosis analysis of stage III/IV patients with lung cancer after treatment with toripalimab: A real-world retrospectivedoi:10.4103/jcrt.jcrt_500_24Real-worldclinical featureslung cancerprognosis analysistoripalimabToripalimab is the first antitumor programmed cell death protein 1...
Group 2 patients had a better prognosis than Group 1 patients (P = 0.0028) but there were no differences in prognosis between Groups 2 and 3 and between Groups 1 and 3. Of potential prognostic factors examined, female gender (P = 0.00012), age > or = 60 (P = 0.00000), KPS > or ...
and prognosis in patients with stage IV non-small cell lung cancer (NSCLC) treated with thoracic three-dimensional radiotherapy and systemic chemotherapy. MET... FMD Amor - 《Radiation Oncology》 被引量: 12发表: 2001年 加载更多来源期刊 International Journal of Radiation Oncology Biology Physics 研...
Patients with stage I lung cancer can be offered surgical treatment with an excellent prognosis for recovery and long-term cure. The recent revision of the staging definition has rearranged the prognostic categories, further improving the prognosis in Stage I disease by eliminating patients with a hi...
Keywords: lung cancer prognosis; lung cancer stages; lung cancer stage classification; prognostic factors; TNM classification 学习笔记 1.首先从整个TNM分期委员会传递出来的信息是:TNM分期是一种肿瘤解剖学范围, 解剖学外仍然有很多因素(如patient-related...
Afatinib, an irreversible ErbB-family blocker, could improve the survival of advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer patients (NSCLCm+). This phase II trial (NCT04201756) aimed to assess the feasibility of neoadjuvant Afatinib treatment for stage III NSCLC...
Clinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancersClinical stage T3N0 non-small cell lung cancer (NSCLC) has a better prognosis than other Stage IIIA lung cancersdoi:10.1016/0169-5002(94)94477-6None...
Clinical Study of 3DCRT Combined with SBRT in the Treatment of Patients with EGFR Mutation Oligometastatic Non-Small Cell Lung Cancer Aims. To investigate the efficacy and prognosis of 3DCRT combined with local SBRT in patients with EGFR mutation oligometastatic NSCLC. Materials and Methods... D ...
Therefore, further classification beyond pT and pN staging and other pathological features influencing stage III CC outcomes remains of interest to refine risk classification and to guide adjuvant treatment.3,8,9 Tumor budding (Bd), defined as a single cancer cell of up to four cancer cells at ...
Pathologic stage Ⅰ non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen:Clinicopathologic characteristics and prognosis[J]... H Matsuguma,R Nakahara,S Igarashi,... - 《Journal of Thoracic & Cardiovascular Surgery》 被引量: 101发表: 2008年 Prognostic value of ...